Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.05 USD
Change Today -0.15 / -2.42%
Volume 1.6M
TXMD On Other Exchanges
Symbol
Exchange
Stuttgart
As of 8:04 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

therapeuticsmd inc (TXMD) Snapshot

Open
$6.20
Previous Close
$6.20
Day High
$6.20
Day Low
$5.85
52 Week High
03/24/15 - $6.75
52 Week Low
05/7/14 - $3.42
Market Cap
1.0B
Average Volume 10 Days
2.1M
EPS TTM
$-0.36
Shares Outstanding
171.7M
EX-Date
06/6/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for THERAPEUTICSMD INC (TXMD)

Related News

No related news articles were found.

therapeuticsmd inc (TXMD) Related Businessweek News

No Related Businessweek News Found

therapeuticsmd inc (TXMD) Details

TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, vitamin D supplements, and natural menopause relief products under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal discomfort. In addition, it manufactures and distributes branded and generic prescription prenatal, as well as OTC vitamins. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

100 Employees
Last Reported Date: 03/12/15
Founded in 2008

therapeuticsmd inc (TXMD) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $448.3K
President, Secretary and Director
Total Annual Compensation: $363.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $324.6K
Chief Strategy Officer and Executive Vice Pre...
Total Annual Compensation: $200.0K
Compensation as of Fiscal Year 2013.

therapeuticsmd inc (TXMD) Key Developments

TherapeuticsMD, Inc. Announces Executive Changes

TherapeuticsMD, Inc. announced that on March 18, 2015, the board of directors appointed Mr. Angus C. Russell and Mr. J. Martin Carroll to serve as directors. Mr. Russell previously served as chief executive officer of Shire PLC. Mr. Carroll previously served as president and chief executive officer of Boehringer Ingelheim Corp. from 2003 until 2011 and as global head of strategy and development for Boehringer Ingelheim (Germany) from 2009 through 2012. The Board has determined that each of Mr. Russell and Mr. Carroll is independent under the rules of the NYSE MKT. As directors of the company, each of Mr. Russell or Mr. Carroll will receive compensation in the same manner as the company's other directors, which compensation the company previously disclosed in its definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 17, 2014. Also on March 18, 2015, Mr. Randall Stanicky resigned from his position as a director. To the knowledge of the company, Mr. Stanicky did not resign as the result of any disagreement between himself and the company.

TherapeuticsMD, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

TherapeuticsMD, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, revenue was approximately $4.3 million compared with approximately $2.9 million in the prior year's quarter. Net operating loss was approximately $16.3 million or $0.10 per basic and diluted share, compared with approximately $8.4 million or $0.06 per basic and diluted share for 2013. Loss before taxes was $16,302,581 against $8,379,139, a year ago. Net loss was $16,302,581 or $0.10 per basic and diluted share against $8,379,139 or $0.06 per basic and diluted share a year ago. For the year, the company’s net revenue was approximately $15.0 million compared with approximately $8.8 million for the prior year. Revenue growth during the fourth quarter and full-year of 2014 was primarily driven by increased sales of the company’s prenatal vitamin products, including the launch of new products and volume growth of existing products. Net operating loss was approximately $54.2 million or $0.36 per basic and diluted share, compared with approximately $28.4 million or $0.22 per basic and diluted share for 2013. Loss before taxes was $54,217,210 against $28,419,313, a year ago. Net loss was $54,217,210 or $0.36 per basic and diluted share against $28,419,313 or $0.22 per basic and diluted share a year ago. Net cash flows used in operating activities was $45,520,996 against $20,768,069, a year ago. Purchase of property and equipment was $30,962 against $40,790, a year ago.

TherapeuticsMD, Inc. to Report Q4, 2014 Results on Mar 10, 2015

TherapeuticsMD, Inc. announced that they will report Q4, 2014 results at 4:00 PM, US Eastern Standard Time on Mar 10, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TXMD:US $6.05 USD -0.15

TXMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TXMD.
View Industry Companies
 

Industry Analysis

TXMD

Industry Average

Valuation TXMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 64.4x
Price/Book 20.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 67.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAPEUTICSMD INC, please visit www.therapeuticsmd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.